Rapid evolution of the human
immunodeficiency virus (HIV) is slowing its ability to cause AIDS,
according to a study of more than 2,000 women in Africa.
Scientists said the research
suggests a less virulent HIV could be one of several factors
contributing to a turning of the deadly pandemic, eventually leading to
the end of AIDS.
"Overall we are bringing down the
ability of HIV to cause AIDS so quickly," Philip Goulder, a professor
at Oxford University who led the study, said in a telephone interview.
"But it would be overstating it to say HIV has lost its potency — it’s still a virus you wouldn’t want to have."
Some 35 million people currently have HIV and AIDS has killed around 40 million people since it began spreading 30 years ago.
But campaigners noted on Monday
that for the first time in the epidemic’s history, the annual number of
new HIV infections is lower than the number of HIV positive people being
added to those receiving treatment, meaning a crucial tipping point has
been reached in reducing deaths from AIDS.
Goulder’s team conducted their
study in Botswana and South Africa — two countries badly hit by AIDS —
where they enrolled more than 2,000 women with HIV.
First they looked at whether the
interaction between the body’s natural immune response and HIV leads to
the virus becoming less virulent or able to cause disease.
Previous research on HIV has
shown that people with a gene known as HLA-B*57 can benefit from a
protective effect against HIV and progress more slowly than usual to
AIDS.
The scientists found that in
Botswana, HIV has evolved to adapt to HLA-B*57 more than in South
Africa, so patients no longer benefited from the protective effect. But
they also found the cost of this adaptation for HIV is a reduced ability
to replicate — making it less virulent.
The scientists then analysed the
impact on HIV virulence of the wide use of AIDS drugs. Using a
mathematical model, they found that treating the sickest HIV patients —
whose immune systems have been weakened by the infection — accelerates
the evolution of variants of HIV with a weaker ability to replicate.
"HIV adaptation to the most
effective immune responses we can make against it comes at a significant
cost to its ability to replicate," Goulder said. "Anything we can do to
increase the pressure on HIV in this way may allow scientists to reduce
the destructive power of HIV over time."
No comments:
Post a Comment